Laboratory Corporation of America (LH) PT Lowered to $160 at Citi

Go back to Laboratory Corporation of America (LH) PT Lowered to $160 at Citi

Laboratory Corporation of America (LH) PT Lowered to $165 at Barclays Following 4Q Guidance Reduction

December 3, 2018 7:39 AM EST

Barclays analyst Jack Meehan lowered the price target on Laboratory Corporation of America (NYSE: LH) to $165.00 (from $205.00) while maintaining a Overweight rating following the company's reduction in 4Q guidance.

The magnitude of the reduction so shortly after the company reduced guidance with 3Q... More